HIGHLIGHTS
- who: Guoju You and colleagues from the We recruited two healthy donors and treated them with recombinant, CSF (filgrastim have published the paper: Cell Discovery immune hyporesponsiveness in G-CSF-primed human bone marrow by single-cell RNA-seq, in the Journal: (JOURNAL)
- what: The study was approved by the Ethics Committee of Peking University People's Hospital and was conducted in accordance with
- how: Consistent with the previous studies186364 the data showed that CD4+ T_cells tended to be Th2 polarized with the downregulation of proinflammatory pathwayrelated cytokines (e_g IFN-γ). The results showed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.